The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha (Q42979832)

12 November 2017

The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha (English)

1 reference

12 November 2017

1 reference

7

G Gerken

1 reference

Karl-Hermann Meyer zum Büschenfelde

12 November 2017

6

object named as

K H Meyer zum Büschenfelde

1 reference

12 November 2017

H F Löhr

1

1 reference

12 November 2017

C Elste

2

1 reference

12 November 2017

H P Dienes

3

1 reference

12 November 2017

G Michel

4

1 reference

12 November 2017

H B Braun

5

1 reference

12 November 2017

1 September 1996

1 reference

12 November 2017

Journal of Hepatology

1 reference

12 November 2017

25

1 reference

12 November 2017

3

1 reference

12 November 2017

292-300

1 reference

Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Early events in hepatitis C virus infection of chimpanzees.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

New kit on the block: Evaluation of second-generation assays for detection of antibody to the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

A role for hepatitis C virus infection in type II cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Autoantibodies and antigens in liver diseases--updated

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Reliability of polymerase chain reaction for detection of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Evaluation of different serum RNA extraction protocols using quantitative HCV-PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

HCV replication in mononuclear cells stimulates anti‐HCV‐secreting B cells and reflects nonresponsiveness to interferon‐α

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Effect of interferon-alpha 2b on cryoglobulinemia related to hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

Cryoglobulinemia with vasculitis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980114-0

7 January 2021

10.1016/S0168-8278(96)80114-0

Identifiers

DOI

1 reference

12 November 2017

1 reference